Lipopolysaccharide-binding protein is a distinctive biomarker of abnormal pain threshold in the general Japanese population.
Kazuhiro KudohHiroki MizukamiChieko ItabashiNobuo FukeSho OsonoiYuki TakeuchiKanichiro WadaAkiko IgawaSaori OgasawaraYasuyuki IshibashiKenichi HakamadaSoroku YagihashiShigeyuki NakajiPublished in: BMJ open diabetes research & care (2021)
Individuals with high LBP exhibited an elevated PINT in the Japanese population. Low level of inflammation evoked by metabolic endotoxemia is possibly implicated in the pathophysiology of SFN from pre-diabetic stage.